Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Larval Zebrafish Model for FDA-Approved Drug Repositioning for Tobacco Dependence Treatment

  • Margot A. Cousin,

    Affiliations Mayo Addiction Research Center, Mayo Clinic, Rochester, Minnesota, United States of America, Center for Clinical and Translational Science, Mayo Clinic, Rochester, Minnesota, United States of America

  • Jon O. Ebbert,

    Affiliations Mayo Addiction Research Center, Mayo Clinic, Rochester, Minnesota, United States of America, Nicotine Dependence Center, Mayo Clinic, Rochester, Minnesota, United States of America

  • Amanda R. Wiinamaki,

    Affiliation Mayo Addiction Research Center, Mayo Clinic, Rochester, Minnesota, United States of America

  • Mark D. Urban,

    Affiliation Mayo Addiction Research Center, Mayo Clinic, Rochester, Minnesota, United States of America

  • David P. Argue,

    Affiliation Mayo Addiction Research Center, Mayo Clinic, Rochester, Minnesota, United States of America

  • Stephen C. Ekker,

    Affiliations Mayo Addiction Research Center, Mayo Clinic, Rochester, Minnesota, United States of America, Center for Clinical and Translational Science, Mayo Clinic, Rochester, Minnesota, United States of America

  • Eric W. Klee

    klee.eric@mayo.edu

    Affiliations Mayo Addiction Research Center, Mayo Clinic, Rochester, Minnesota, United States of America, Center for Clinical and Translational Science, Mayo Clinic, Rochester, Minnesota, United States of America

Viewed

Cited

Saved

Discussed

Powered by Altmetric
Questions or concerns about usage data? Please let us know.